Literature DB >> 16452616

Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.

Roger A Moore1, Christian Herzog, John Errett, David A Kocisko, Kevin M Arnold, Stanley F Hayes, Suzette A Priola.   

Abstract

A central feature of transmissible spongiform encephalopathies (TSE or prion diseases) involves the conversion of a normal, protease-sensitive glycoprotein termed prion protein (PrP-sen) into a pro-tease-resistant form, termed PrP-res. The N terminus of PrP-sen has five copies of a repeating eight amino acid sequence (octapeptide repeat). The presence of one to nine extra copies of this motif is associated with a heritable form of Creutzfeld-Jakob disease (CJD) in humans. An increasing number of octapeptide repeats correlates with earlier CJD onset, suggesting that the rate at which PrP-sen misfolds into PrP-res may be influenced by these mutations. In order to determine if octapeptide repeat insertions influence the rate at which PrP-res is formed, we used a hamster PrP amyloid-forming peptide (residues 23-144) into which two to 10 extra octapeptide repeats were inserted. The spontaneous formation of protease-resistant PrP amyloid from these peptides was more rapid in response to an increased number of octapeptide repeats. Furthermore, experiments using full-length glycosylated hamster PrP-sen demonstrated that PrP-res formation also occurred more rapidly from PrP-sen molecules expressing 10 extra copies of the octapeptide repeat. The rate increase for PrP-res formation did not appear to be due to any influence of the octapeptide repeat region on PrP structure, but rather to more rapid binding between PrP molecules. Our data from both models support the hypothesis that extra octapeptide repeats in PrP increase the rate at which protease resistant PrP is formed which in turn may affect the rate of disease onset in familial forms of CJD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452616      PMCID: PMC2249780          DOI: 10.1110/ps.051822606

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  64 in total

1.  Glycosylation influences cross-species formation of protease-resistant prion protein.

Authors:  S A Priola; V A Lawson
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Mutant prion proteins are partially retained in the endoplasmic reticulum.

Authors:  L Ivanova; S Barmada; T Kummer; D A Harris
Journal:  J Biol Chem       Date:  2001-08-29       Impact factor: 5.157

3.  Structural features of the Abeta amyloid fibril elucidated by limited proteolysis.

Authors:  I Kheterpal; A Williams; C Murphy; B Bledsoe; R Wetzel
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

4.  Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.

Authors:  R Chiesa; B Drisaldi; E Quaglio; A Migheli; P Piccardo; B Ghetti; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Reversibility of scrapie-associated prion protein aggregation.

Authors:  M A Callahan; L Xiong ; B Caughey
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

6.  Rapidly progressive dementia syndrome associated with a novel four extra repeat mutation in the prion protein gene.

Authors:  C Yanagihara; M Yasuda; K Maeda; K Miyoshi; Y Nishimura
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

7.  Protein interactions leading to conformational changes monitored by limited proteolysis: apo form and fragments of horse cytochrome c.

Authors:  B Spolaore; R Bermejo; M Zambonin; A Fontana
Journal:  Biochemistry       Date:  2001-08-14       Impact factor: 3.162

Review 8.  Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia.

Authors:  Pierluigi Gambetti; Piero Parchi; Shu G Chen
Journal:  Clin Lab Med       Date:  2003-03       Impact factor: 1.935

Review 9.  A murine model of a familial prion disease.

Authors:  David A Harris; Roberto Chiesa; Bettina Drisaldi; Elena Quaglio; Antonio Migheli; Pedro Piccardo; Bernardino Ghetti
Journal:  Clin Lab Med       Date:  2003-03       Impact factor: 1.935

10.  Novel prion protein insert mutation associated with prolonged neurodegenerative illness.

Authors:  V Lewis; S Collins; A F Hill; A Boyd; C A McLean; M Smith; C L Masters
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

View more
  33 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Structural polymorphism in amyloids: new insights from studies with Y145Stop prion protein fibrils.

Authors:  Eric M Jones; Bo Wu; Krystyna Surewicz; Philippe S Nadaud; Jonathan J Helmus; Shugui Chen; Christopher P Jaroniec; Witold K Surewicz
Journal:  J Biol Chem       Date:  2011-10-15       Impact factor: 5.157

3.  Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.

Authors:  Christopher J Choi; Vellareddy Anantharam; Dustin P Martin; Eric M Nicholson; Jürgen A Richt; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

4.  Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions.

Authors:  Jijun Dong; Jesse D Bloom; Vladimir Goncharov; Madhuri Chattopadhyay; Glenn L Millhauser; David G Lynn; Thomas Scheibel; Susan Lindquist
Journal:  J Biol Chem       Date:  2007-09-24       Impact factor: 5.157

Review 5.  Insights into intragenic and extragenic effectors of prion propagation using chimeric prion proteins.

Authors:  Heather L True; Tejas Kalastavadi; Elizabeth M H Tank
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

6.  Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils.

Authors:  Jonathan J Helmus; Krystyna Surewicz; Philippe S Nadaud; Witold K Surewicz; Christopher P Jaroniec
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

7.  Thermodynamic characterization of the unfolding of the prion protein.

Authors:  Roumita Moulick; Jayant B Udgaonkar
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

Review 8.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  The octarepeat region of the prion protein is conformationally altered in PrP(Sc).

Authors:  Alice Y Yam; Carol Man Gao; Xuemei Wang; Ping Wu; David Peretz
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

10.  Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.

Authors:  Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew F Hill
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.